When.com Web Search

  1. Ads

    related to: what drugs are in symbicort generic

Search results

  1. Results From The WOW.Com Content Network
  2. Budesonide/formoterol - Wikipedia

    en.wikipedia.org/wiki/Budesonide/formoterol

    Budesonide/formoterol, sold under the brand name Symbicort among others, is a fixed-dose combination medication used in the management of asthma or chronic obstructive pulmonary disease (COPD). [2] It contains budesonide , a steroid ; and formoterol , a long-acting β 2 -agonist (LABA). [ 2 ]

  3. Formoterol - Wikipedia

    en.wikipedia.org/wiki/Formoterol

    Formoterol is marketed in three forms: a dry-powder inhaler (DPI), a metered-dose inhaler (MDI) and an inhalation solution, under various brand names including Atock, Atimos/Atimos Modulite, Foradil/Foradile, Fostair, Oxeze/Oxis, Perforomist and Symbicort. Foradil/Foradile capsules for oral inhalation (Schering-Plough in the U.S., Novartis rest ...

  4. List of largest selling pharmaceutical products - Wikipedia

    en.wikipedia.org/wiki/List_of_largest_selling...

    Drug Main indication Trade name 2015 2016 ... Generic Name Sales Q1 2014 Sales ... Symbicort: Budesonide/formoterol: 407,646:

  5. Viatris (VTRS) Wins in Court Against AstraZeneca's Symbicort

    www.aol.com/news/viatris-vtrs-wins-court-against...

    Viatris (VTRS) and its partner win a court decision that invalidates branded drug Symbicort's patent and opens the door for them to launch their generic version of the drug.

  6. Budesonide - Wikipedia

    en.wikipedia.org/wiki/Budesonide

    [37] [42] Drugs that are CYP3A4 inhibitors such as ketoconazole, clarithromycin, ritonavir, and nefazodone, among many others, may inhibit the metabolism of Budesonide, prolonging its elimination and leading to possible increased rates of corticosteroid adverse effects due to unwanted drug accumulation.

  7. Viatris - Wikipedia

    en.wikipedia.org/wiki/Viatris

    Breyna (budesonide and formoterol fumarate dihydrate inhalation aerosol): In March 2022, received approval from the US FDA in March 2022 as the first generic version of Symbicort for the treatment of asthma and COPD. [38] [39]